Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures.
about
Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Genomic Impact of Neoadjuvant ...... ed Diagnostic Gene Signatures.
@en
Genomic Impact of Neoadjuvant ...... ed Diagnostic Gene Signatures.
@nl
type
label
Genomic Impact of Neoadjuvant ...... ed Diagnostic Gene Signatures.
@en
Genomic Impact of Neoadjuvant ...... ed Diagnostic Gene Signatures.
@nl
prefLabel
Genomic Impact of Neoadjuvant ...... ed Diagnostic Gene Signatures.
@en
Genomic Impact of Neoadjuvant ...... ed Diagnostic Gene Signatures.
@nl
P2093
P2860
P1476
Genomic Impact of Neoadjuvant ...... ed Diagnostic Gene Signatures.
@en
P2093
Erin Yoder
James Pellicane
Mark Gittleman
NBRST Investigators Group
Pat Whitworth
Paul Baron
Peter Beitsch
Tina Treece
P2860
P2888
P304
P356
10.1245/S10434-016-5329-6
P577
2016-07-06T00:00:00Z
P6179
1009335050